SUMMARY ANSWER: In vitro, short exposure to supra-physiological concentrations of BPA alters human MGC gene expression.
Introduction
Bisphenol-A (BPA) is a synthetic substance produced at one of the highest volumes in the plastic industry, and there is ubiquitous exposure of the general population (Vandenberg et al., 2007; Calafat et al., 2008; Ye et al., 2015) . Sources of BPA exposure include the lining of cans used for food and beverages, polycarbonate bottles, thermal receipts, etc. (Vandenberg et al., 2007; Talsness et al., 2009 ). Exposure to this chemical has been found to interfere with reproductive endocrine signaling mainly in animal models (Vandenberg et al., 2007; Caserta et al., 2008) .
BPA has been detected in human biofluids including urine, serum, amniotic fluid, and follicular fluid (Ikezuki et al., 2002) . According to the National Health and Nutrition Examination Survey (NHANES) of the US Centers for Disease Control reported in 2015, the geometric mean urinary concentrations of BPA measured were 1.83 µg/l (CDC, 2015) . BPA was previously detected in follicular fluid at concentrations of 1-2 ng/ml (Ikezuki et al., 2002) . However, these follicular fluid measurements should be interpreted with caution as the fluid was collected during oocyte retrieval from patients who were fasting overnight. The primary route of BPA exposure is considered dietary (Wilson et al., 2007) and, given its short half-life (6 h), levels would be expected to be lower as a result of fasting (Volkel et al., 2002; Teeguarden et al., 2005; Thayer et al., 2015) .
In vitro and in vivo studies have shown an inverse correlation between BPA exposure and follicular growth, oocyte maturation, spindle formation and steroid hormone production in granulosa cells; these findings were mainly in animal studies (Hunt et al., 2003; Can et al., 2005; Eichenlaub-Ritter et al., 2008; Peretz et al., 2011) , but human model systems also exhibit significant effects often at supra-physiological levels (Kwintkiewicz et al. 2010; Ehrlich et al., 2013; Machtinger et al., 2013; Mansur et al., 2016 ; reviewed by Machtinger and Orvieto 2014;  reviewed by Peretz et al., 2014) . We have recently shown that BPA exposure at supra-physiological concentrations (≥2 µg/ml) impairs steroidogenesis in human granulosa cells in vitro using qRT-PCR and western blotting (Mansur et al., 2016) . The aim of this study was to expand our previous work and to identify changes in the global gene expression profile (using a microarray approach and confirmation by quantitative RT-PCR [qRT-PCR] ) in primary cultures of human membrana granulosa cells (MGCs) treated with a range of BPA concentrations. To assess if BPA impairs gene expression in doses relevant to human exposure, the lowest concentration tested was equivalent to that previously detected in human follicular fluid and urine (Ikezuki et al. 2002; Ye et al., 2015) .
Materials and Methods

Study participants
This study was approved by our local institutional review board, and all participants provided written informed consent. MGC, which are typically discarded, were collected from patients undergoing IVF. Inclusion criteria were patients aged 37 years or younger, BMI ≤ 30 kg/m², who were undergoing fertility treatments for male infertility factor or unexplained infertility, as well as fertile couples undergoing IVF for PGD of autosomal recessive diseases. Patients with polycystic ovary syndrome, diminished ovarian reserve or endometriosis, which might impair granulosa cell gene expression, were excluded.
Cell collection and preparation
MGC were collected from follicular aspirates from 24 patients, 3 of whom contributed cells to our previous study (Mansur et al., 2016) . Cells were prepared and purified as described previously (Ferraro et al., 2012; Mansur et al., 2016) .
Treatment protocol
Cells were cultured in 12-well plates (250 000 and 100 000 live cells/well for microarray and real-time PCR, respectively) for 48 h at 37°C as previously described (Mansur et al., 2016) .
The number of cells differed for the microarray and real-time PCR experiments since higher concentrations of RNA were needed for the assessment of the quality and integrity of the RNA before microarray, as compared with those required for PCR analyses. Granulosa cells were treated with androstene-3, 17 dione as an androgenic substrate for the production of estradiol. The medium was then replaced by the same medium formulation containing FSH (Merck Serono, Switzerland) (final concentration of 73.3 ng/ml) and different concentrations of BPA: 0, 0.02 µg/ml, 0.2 µg/ml, 2 µg/ml or 20 µg/ml for 48 h (Kwintkiewicz et al., 2010; Mansur et al., 2016) . The lowest BPA concentration was equivalent to that previously detected in human follicular fluid (Ikezuki et al., 2002) ; supra-physiological concentrations matched those tested in previous in vitro studies (Grasselli et al., 2010; Peretz et al, 2011; Machtinger et al., 2013) . Dimethylsulphoxide (DMSO) 99% (AMRESCO, Canada) served as a vehicle with a final DMSO concentration of 0.05%. The control contained the same concentration of 0.05% DMSO.
RNA extraction and microarray analysis
After treatment, cells were lysed in 300 µl of RNA lysis buffer according to the manufacturer's instructions (Quick-RNA Microprep Kit; Zymo Research, Orange, CA, USA). The concentration of isolated RNA was determined using a NanoDrop 2000 C spectrophotometer (Thermo Scientific, Waltham, MA, USA). The RNA extracts were stored at −80°C until analysis. The quality and integrity of RNA samples were analyzed using Gel Agarose (Lonza Inc., Allendale, NJ, USA) in a gel electrophoresis system (Mini Gel Migration Trough; Cosmo Bio, CA, USA). Only samples containing RNA that was not degraded were included.
Microarray analysis was used to identify significant differences in gene expression after BPA treatment. Total RNA was extracted from MGC using a Quick-RNA Microprep Kit (Zymo Research) according to the manufacturer's instructions. RNA was isolated from each well of MGC after exposure of cells to one of five concentrations of BPA, with 100 ng of RNA used for this analysis. This experiment was performed three times using cells collected from seven different women. Biotinylated target RNA was prepared according to the manufacturer's instructions with minor modifications. Briefly, the RNA isolated from the MGC was used to generate first-strand cDNA with a T7-linked oligo (dT) primer; next, a second strand of cDNA was produced and in vitro transcription was performed with biotinylated UTP and CTP, resulting in an~300-fold amplification of the RNA (GeneChip® 3′ IVT Express Kit; Affymetrix, Cat. No. 901253., USA). GeneChip prime view human (Affymetrix, Cat. No. 901837., USA) was used in the microarray experiments, and the target cDNA generated from each sample was processed per the manufacturer's recommendations using an Affymetrix GeneChip Instrument System. Spike controls were added to 15 µg fragmented cRNA before overnight hybridization at 45°C and rotated at 60 rpm according to the manufacturers' instructions (http://media. affymetrix.com/support/downloads/manuals/3_ivt_express_kit_manual.pdf). Arrays were then washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip scanner. After scanning, array images were assessed by eye to confirm scanner alignment and the absence of bubbles or scratches on the chip surface. The 3′/5′ ratios for GAPDH and β-actin were confirmed to be within acceptable limits, and BioB spike controls were found to be present on all chips, with BioC, BioD and CreX also present in increasing intensity. qRT-PCR was used to validate RNA samples. Analysis of data was performed by RMA (Partec Inc., St. Louis, MO, USA) software in the Department of the Cancer Research in our hospital.
Measurement of gene expression by real-time PCR
For the qRT-PCR, we used both pooled samples (2-3 patients) and individual samples that were collected from another 17 independent patients who fulfilled the inclusion criteria and did not contribute cells to the microarray experiments. We selected eight genes for validation: Baculoviral IAP RepeatContaining 5 (BIRC5), Budding Uninhibited by Benzimidazoles 1 (BUB1B), Cyclin B1 (CCNB1), Cell Division Cycle 20 (CDC20), hydroxy-3-methylglutarylCoA synthase 1 (HMGCS1), insulin-like growth factor binding protein 1 (IGFBP1), Mitotic Arrest Deficient-Like 1 (MAD2L1) and tribbles homolog 3 (TRIB3). Candidate genes were selected for validation according to their involvement in the enriched functional annotations altered by BPA at the concentration of 20 µg/ml representing high fold-changed genes. Each assay was replicated eight or nine times in different cultures. Total RNA was extracted from MGC using a Quick-RNA Microprep Kit (Zymo Research) according to the manufacturer's instructions. RNA concentrations were assessed using a NanoDrop 2000 C spectrophotometer (Thermo Scientific, Waltham, MA, USA). Twenty-five nanograms of RNA were added to the reverse transcription reaction mix to produce 10 μl cDNA by high-capacity cDNA RT kit (Applied Biosystems, Carlsbad, CA, USA) according to the manufacturer's instructions. Fluorescent SYBR Green PCR mix (Applied Biosystems) was used to quantify PCR products. Specific primers (final concentration of 0.4 µM) for the genes (Table I) were added, and a final volume of 10 µl was used for the PCR reaction. β-actin was used as a reference gene for each sample. Primers were generated using the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/nucleotide) and were all intron-exon spanning to avoid genomic DNA contamination. Amplification and detection were performed using the StepOnePlus real-time PCR system (Zymo Research) with the following profile: 1 cycle at 95°C for 20 seconds, 40 cycles each at 95°C for 3 seconds and 60°C for 30 seconds. One microliter of cDNA was used per reaction in a 10-µl total reaction volume. All samples were run in triplicate. The same qRT-PCR protocol was used for all genes analyzed. The 2 −ΔΔCt method was used to obtain the relative gene expression data (fold change with respect to non-treated sample) (Adnan et al., 2011) . NM_021158.4
Statistical analysis
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2-fold relative to the control group and a Student's t-test P-value <0.05.
Only genes that were changed >2-fold were included in the statistical analysis. Statistical significance was adjusted for multiple comparisons using the Benjamini-Hochberg method. For the qRT-PCR, data were analyzed using SPSS statistical software version 23.0 (SPSS Inc., Chicago, IL, USA). Data were expressed as mean ± SE, and results for each different BPA concentration were compared against control by Student's t-test. Adjustments were made to the alpha level for multiple comparisons between the groups by applying Bonferroni correction (four comparisons). P < 0.05 was considered statistically significant.
The set of differentially expressed genes was used to identify functional annotations and pathways most likely to be involved in the observed gene expression changes. Genes were identified using QIAGEN's Ingenuity® Pathway Analysis (IPA®, Qiagen Inc. Valencia, CA, USA).
Results
The primary cultures of MGC used in this study were collected from 24 women, ranging from 22.7 to 36.3 years of age (31.1 ± 3.7 years, mean ± SD). Participants underwent IVF for PGD (54.1%), male factor infertility (33.3%), or unexplained infertility (12.5%). Seventy-nine percent of the participants underwent controlled ovarian hyperstimulation with a GnRH antagonist, and 21% underwent a long-term GnRH agonist suppressive protocol. Ovidrelle (Merck Serono) was used as the pre-ovulatory hCG trigger in 22/24 of the cases (92%), and GnRH agonist (Decapeptyl 0.2 mg, Ferring, Switzerland) in another two cases (8%). Figure 1 displays principal components analysis plots of gene expression, observed in the three different experiments. This analysis shows that samples from the same experiment display related gene expression patterns, except for samples exposed to the highest concentration of BPA, which appear as a separate group. When compared to untreated cells, exposure to 20 µg/ml BPA resulted in significant differences in expression of 721 transcripts (>2-fold; P < 0.05). These transcripts corresponded to 652 distinct genes. No significant differences in gene expression were observed for the lower doses of BPA (0.02, 0.2 and 2 µg/ml) compared with controls. Figure 2 presents a gene expression heatmap of the transcripts differentially expressed when exposed to 20 µg/ml BPA, with a hierarchical clustering dendrogram for samples and genes. expression. Each MGC sample is represented by a colored shape, with color indicating the bisphenol-A (BPA) concentration to which the sample was exposed, and shape indicating the cell extract origin (P1 = Experiment 1, P2 = Experiment 2, P3 =Experiment 3). Samples exposed to the highest concentration of BPA appear as a separate group (surrounded by a black ellipse), samples exposed to lesser concentrations display gene expression patterns primarily reflecting the cell extract origin (grouped inside the colored ellipses).
Functional annotations of differentially expressed genes
We used ingenuity pathway analysis (IPA) to identify enrichment of functional annotations and to determine cellular functions most likely to be affected by the changes in gene expression observed following BPA exposure. We identified significant enrichment in 652 genes with at least 2-fold change and P < 0.05 following BPA exposure at 20 µg/ml. Among the most enriched functional annotations were cell cycle progression (P = 4.52 × 10 ), and attachment of spindle fibers (P = 3.7 × 10 −3 ) (Fig. 3) .
Confirmation of BPA-induced changes in expression by qRT-PCR
Selection criteria for the validation of candidate genes were: a high fold change after exposure to BPA at the highest concentration of 20 µg/ml; hybridization intensity; and biological relevance to the most enriched functional annotations described above. Specifically, we chose to focus our analysis on genes involved in cell cycle progression, mitosis, M-phase, chromosomal segregation, steroid, lipid metabolism and spindle formation. Candidate genes with significant fold changes and known functions in these processes (BIRC5, BUB1B, CCNB1, CDC20, HMGCS1, IGFBP1, MAD2L1 and TRIB3) were selected for validation. Expression changes (increases and decreases) observed by microarray analysis were indeed confirmed by qRT-PCR (Figs 4 and 5 ).
Discussion
Our results show that in vitro exposure to a high supra-physiological level of BPA (20 µg/ml) alters genes that are involved in cell cycle progression, cell death and survival, apoptosis, lipid and steroid metabolism, mitosis, segregation and alignment of chromosomes and oocyte maturation. We confirmed by qRT-PCR the effect of BPA on a selection of eight representative genes.
The most pronounced changes after BPA exposure that are also relevant to ovarian physiology were an increase in TRIB3 and IGFBP1 and a decrease in HMGCS1. Brisard et al. (2014) recently described higher levels of TRIB3 in cumulus cells from mature compared to immature oocytes and suggested that this gene can be involved in the regulation of lipid metabolism via control of peroxisome proliferatoractivated receptor gamma (PPARG) activity. These results are in line with Kwintkiewicz et al. (2010) who showed that BPA was associated with overexpression of PPARG in granulosa cell lines. Moreover, TRIB3 is a key mediator of insulin signaling (Prudente et al., 2012) .
IGFBP1 is involved in glucose metabolism (Crossey et al., 2000) . In female reproduction, IGFBP1 is important for follicular growth, ovulation, steroidogenesis and implantation (Fowler et al., 2000) .
Finally, HMGCS1 is important for the synthesis of cholesterol from acetyl CoA (Kessler et al., 2014) . A decrease in HMGCS1 is in line with our recent findings that supra-physiological concentrations of BPA affect steroid hormone synthesis in MGC (Mansur et al., 2016) . The effects of BPA on these genes associated with glucose and lipid metabolism are relevant to other reports that BPA plays a role in obesity, as previously reviewed (Heindel, 2015) .
Oocytes depend on granulosa cells for their growth and for the regulation of meiosis. Since experimentation with human oocytes is limited by sample availability, the use of primary cultures of MGC system can serve as a model to understand the effects of BPA on meiotic targets in the oocyte. We previously showed that BPA exposure impairs oocyte maturation, meiotic spindle structure and chromosome alignment in vitro (Machtinger et al., 2013) . These results indicate that BPA exposure affects the expression of genes in MGC that are related to cell cycle control and chromosome segregation (BIRC5, BUB1B, CCNB1, CDC20 and MAD2L1). The microarray findings for these genes were thus confirmed using qRT-PCR. Interestingly, all of the genes with confirmed expression changes are known regulators of oocyte maturation. Furthermore, IPA revealed that these candidate genes interact in a network related to oocyte maturation, spindle formation and chromosome segregation. BIRC5 is essential for tubulin interaction and stabilization of chromosomes (Lamers et al., 2011) . BUB1 participates in chromosome alignment and segregation of oocytes during meiosis (Yin et al., 2006) . MAD2L1, BUB1B and CDC20 play a role in the arrest of meiosis and mitosis by preventing the onset of anaphase in the event of altered chromosome-kinetochore connections, damaged spindles or misaligned chromosomes (Niault, et al., 2007; Luo and Yu, 2008; Chen et al., 2010) . Finally, CCNB1 (cyclin B1) regulates the promotion of meiosis from the germinal vesicle (arrest of Meiosis I) stage to Meiosis II and also plays a role in the condensation of chromosomes (Li et al., 1995; Ookata, et al., 1995; Brunet and Maro, 2005) . Spindle and chromosomal abnormalities are considered crucial factors leading to infertility, aneuploidy and fetal loss (Hunt and Hassold, 2008; Selesniemi et al., 2011) . While the effects of BPA on MGC gene expression were significant only at 20 µg/ml, we previously reported significant effects of BPA on oocytes in lower doses (Machtinger et al., 2013) . The difference can indicate that oocytes are more susceptible to BPA compared to granulosa cells. Therefore, we suggest to further test the effects of BPA on cumulus cells, as a subtype of granulosa cells in direct communication with the oocyte.
Apoptosis was among the most enriched functional annotations impaired by BPA. Although validation of these results by RT-PCR were beyond the scope of this study, these findings are in line with previous animal experiments that showed that BPA exposure induced apoptosis and cell G2-to-M arrest in mouse granulosa cells (Xu et al., 2002) and increased follicular atresia in rats and mice (Peretz et al., 2012; Lee et al., 2013) .
A strength of this in vitro study is the inclusion of primary cultures of cells mostly from fertile women. Such inclusion helps to overcome the possible bias and potential variability that may be associated with infertility. Potential inter-patient variability in the sensitivity to BPA and/or metabolism of the chemical is also relevant to consider. In our study, samples from the same experiment (i.e. granulosa cells pooled from the same group of patients) display related gene expression patterns, except for samples exposed to the highest concentration of BPA, Figure 3 Functional groups altered by the changes in mRNA expression level following exposure to 20 µg/ml BPA. Changes in MGC mRNA expression were analyzed with ingenuity pathway analysis (IPA) to identify affected cellular functions. Functional groups identified by IPA had enrichment in 652 genes with at least a 2-fold change following BPA exposure at 20 µg/ml. The length of the bar is proportional to the negative log of the (BenjaminiHochberg FDR corrected) enrichment P-value (This represents the IPA score, thus a longer bar equals a higher score).
which have distinct characteristics (Figure 1 ). As the number of discarded biological samples is inherently limited, it is possible that the microarray analyses and quantitative PCR used in this study cannot confirm minor changes in gene expression that might occur at low concentrations of the chemical. An increased sample size may provide adequate power to reveal more subtle effects.
Our study has several limitations. First, the duration of exposure to BPA was 48 h in vitro, which is in line with previous similar studies (Kwintkiewicz et al., 2010; Mansour et al., 2016) ; however, this duration may not accurately mimic exposure to BPA in vivo. Specifically, human exposure likely occurs over long periods of time, and it is possible that, after an extended duration of exposure to BPA, the effects found in this study might be heightened. A second limitation is related to the in vitro approach. The presence of serum in the culture medium may interfere with the bioavailability and metabolism of BPA, perhaps masking and altering the biological effect. However, no experimental evidence for such interference yet exists. It is also relevant to note that a BPA exposure paradigm in the presence of serum may not be significantly different from the situation in the follicle in vivo, given that the granulosa cells are bathed in a protein-rich complex liquid environment, the follicular fluid, which is a serum exudate. Another possible limitation, resulting from experimentation with clinically discarded material, was the use of only luteinized granulosa cells after exposure to follicular stimulation and the ovulatory trigger of hCG. As such, the findings may not apply to either non-luteinized granulosa cells from earlier stages of follicular development or cumulus cells. Nonetheless, evaluating the effects of BPA in luteinized cells has biological relevance in view of the critical role of the corpus luteum in endometrial priming and support of early pregnancy.
In conclusion, in vitro exposure of granulosa cells to BPA led to a marked alteration in gene expression at a high and supra-physiological dose. Given the very limited data on follicular fluid levels of BPA and the lack of knowledge of the doses of BPA that actually reach the cells in vitro, it is difficult to put these results into the perspective of human health. Recently, increased concern for the effects of BPA has led to the partial replacement of this chemical with other phenols such as bisphenol-S, F, B and AF (Sartain and Hunt, 2016) . Further studies will evaluate if chronic exposure to low levels of BPA or its substitutes both in vitro and in vivo have different effects, and if the transcriptional differences translate to protein differences. Figure 5 The effect of BPA on MGC mRNA expression levels. Changes in mRNA levels were analyzed by qRT-PCR and normalized against b-actin.
Data are mean ± SE. Compared to controls, treatment of 20 μg/ml BPA increased the levels of tribbles pseudokinase 3 (TRIB3 *P = 0.03) and insulin-like growth factor binding protein 1 (IGFBP1 ***P = 0.0003) and decreased the levels of 3-hydroxy-3-methylglutaryl-CoA synthase 1 (HMGCS1 **P = 0.007).
